Bay Colony Advisors’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-28
Closed -$1K 976
2018
Q2
$1K Buy
+28
New +$692 ﹤0.01% 912

Other funds holding LDRS

Bay Colony Advisors's LDRS Position: Q3 2018 in Review

Bay Colony Advisors sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q3 2018, closing a stake of 28 shares — an estimated $1K sold.

Bay Colony Advisors first reported a position in LDRS in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 18 funds tracked by Wall St. Rank hold LDRS as of Q3 2018.

  • Bay Colony Advisors reported no remaining Innovator IBD ETF Leaders ETF position as of Q3 2018 after selling out during the quarter.
  • Bay Colony Advisors sold 28 Innovator IBD ETF Leaders ETF shares in Q3 2018, an estimated $1K.
  • Bay Colony Advisors first reported a position in Innovator IBD ETF Leaders ETF in Q2 2018 and held it in 1 quarter.
  • Bay Colony Advisors's Innovator IBD ETF Leaders ETF position peaked at $1K in Q2 2018.
  • 18 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q3 2018.

Based on Bay Colony Advisors's 13F filing for Q3 2018, filed 5 Nov 2018.